#871: The “Divine Leaf” with 8,000+ Years of Use — Exploring the Many Benefits of Coca with Dr. Andrew Weil and Wade Davis

Pharmacological Differences: Coca Leaf vs. Cocaine Consumption Effects and Safety

Coca leaves contain a complex mixture of at least 14 alkaloids, with cocaine present only in modest amounts, absorbed benignly through the oral mucous membranes when consumed as tea or chewed. Andrew Weil emphasizes that these alkaloids possess similar chemical structures, yet only isolated cocaine has been extensively studied, largely neglecting the synergistic or balancing effects of the remaining compounds. Notably, coca's pharmacological effects are far more versatile than those of isolated cocaine. Weil recounts Andean respondents attesting that coca treats both diarrhea and constipation, a paradox from the standpoint of Western pharmacology. Cocaine is known as a gut stimulant, useful for constipation, yet cannot logically treat diarrhea; however, examining other alkaloids reveals molecules structurally resembling drugs like [restricted term] and [restricted term]—gut paralytics—which could account for coca's dual effects on digestion. Weil suggests that the body, presented with this array of alkaloids, essentially selects the compounds needed for its current physiological state, offering a unique model of whole-plant pharmacology.

Industrial-scale resources are required to extract significant amounts of cocaine from coca leaves, making home extraction impractical due to the large volumes needed.

Whole Plant Coca Safer and More Effective Than Pharmaceutical Stimulants

Users such as Tim Ferriss and Wade Davis report that coca, when consumed as tea or chewed, provides a very gentle stimulant effect—much milder than that of caffeine or pharmaceutical stimulants. Ferriss describes the effects as less than half a cup of coffee, yet without any subsequent crash typical of caffeine or a glucose spike and drop. Weil and Davis highlight that coca offers steady, smooth focus, eliminating existential distractions and neuroses without imparting a “drugged” or overly stimulated feeling. Users find themselves able to maintain creativity, concentration, and productivity throughout the day with no harshness or exhaustion.

The subjective experience further includes a light, well-being “lift” and enhanced physical capability, such as increased stamina at high altitude, reduction in hunger, and encouragement to move the body—without generating a dependency or building up the type of tolerance associated with caffeine, [restricted term], or cocaine. Davis notes that coca supports an emotionally even state, making life more productive and pleasant, but that discontinuation carries no withdrawal. Weil personally attributes improved mood and well-being to regular coca use, and Davis recounts how even daily users, such as Amazonian botanist Richard Evans Schultes, could stop without disruption.

Crucially, coca leaf has been safely integrated into Andean and Amazonian cultures for at least eight thousand years, with no reports of toxicity or addiction despite everyday use throughout the highlands.

Coca Leaves' Nutritional Profile Shows Food-Medicine Qualities Beyond Alkaloids

In 1975, Tim and Jim Duke, along with Andrew Weil, conducted a groundbreaking nutritional study on coca leaves, revealing high concentration ...

Decades-Old Coca Research Suppression and False Narratives Served Cultural-Political Purposes

Efforts to eradicate traditional coca fields began sixty years before the global emergence of a cocaine issue. The campaign was unrelated to the pharmacology of cocaine hydrochloride and was rooted instead in the cultural identity of Indigenous peoples who revered the plant. Physicians and elites in Lima, Peru, targeted coca as a symbol of Indigenous culture and autonomy, which threatened the colonial foundations of their power. They faced a country split in two: the white European elite favored alcohol, while Indigenous populations, especially at high altitude and in the Amazon, relied on coca. The Lima bourgeoisie, faced with economic and land reform demands, projected anxieties about poverty and literacy onto coca, making it the scapegoat for societal ills.

For the Lima elite, coca chewing represented everything opposed to their worldview, and eradicating it equated to an attempt to erase Indigenous culture or force assimilation. This aggressive and prejudicial stance predated any genuine concern about cocaine as a drug. Crop eradication was thus about cultural erasure, not drug control.

During the late 1940s, the United Nations sent a commission led by Howard Fonda, a pharmaceutical executive, to study the so-called "coca problem." This commission announced its anti-coca conclusions before leaving New York and reiterated them upon arrival in Lima. Spending three months in the Andes, the commission consulted only with military officials, local authorities, government representatives, and priests— pointedly avoiding any interviews with traditional coca users. Unsurprisingly, the commission's report echoed its prejudged stance that coca must be eradicated.

Pseudoscientific Language and Racist Ideology in Drug Policy Govern Coca's Legal Status

The condemnation of coca was fueled by pseudoscientific studies and overtly racist language, the legacy of which persists in contemporary international drug policy. Pablo Osvaldo-Wolff, chief of the Addiction Producing Drugs section at the World Health Organization and an acolyte of notorious anti-drug crusader Harry Anslinger, crafted the demonizing language enshrined in the 1961 UN Convention on Narcotic Drugs. Osvaldo-Wolff described coca chewers using terms like "apathetic, lazy, insensitive," alleged that they experienced "moral degeneration," intellectual decline, heightened criminality, and likened them to "slaves." He further claimed that their children were "markedly deficient in intelligence" and blamed coca for the backwardness and misery of Indigenous populations—an outlook steeped in colonial racism.

Wade Davis highlights the shocking reality that these racist and pseudoscientific views are embedded in the very regulations and conventions that still dictate international drug policies today. The very architects of this language and policy never conducted rigorous scientific studies or sought empirical understanding. Instead, these policies enshrined prejudice and ignored any evidence to the contrary.

Despite coca’s medicinal potential, attempts to reschedule it within international regulatory frame ...

Coca's Central Role in Andean and Amazonian Indigenous Culture

The coca leaf, with over 8,000 years of documented human use, stands at the heart of Indigenous culture throughout the Andes and Amazon. It is central not only as a ritual and religious item but also as a core element of daily life, health, and social fabric. In Peru, Colombia, and among the Kogis, coca is seen as both a cultural and medicinal staple—comparable to peppermint and chamomile in European medicine. Its primary medicinal use is for treating gastrointestinal issues, but it is equally valued for boosting energy, alleviating altitude sickness, lifting mood, and improving metabolism, especially among Andean populations with limited nutrition.

A common practice across the Andes is the creation of the crissettia, a ritual involving three perfect coca leaves arranged in a fan shape. This three-leaf offering is made to the sacred mountains, symbolizing a person's connection to the land and an obligation to preserve its sanctity. The ritual involves pointing the bundle to the mountain and blowing the energy of the leaf, mirroring the clouds that bring rain and fertility to the soil, thus reinforcing one’s sacred bond with the landscape.

Coca is not only used in individual rituals but is integral to nearly every communal activity. When fields are planted, coca is sprinkled as an offering to Pachamama, the Earth Mother, establishing and honoring the social contract between people and land. Tools brought back in the evening are greeted with coca, underscoring its symbolic role in uniting families and communities.

Coca is deeply embedded in life-cycle traditions. The practice of chewing leaves—central to expressing the identity of being "runa kuna," a true Andean person—begins at marriageable age. To deny access to coca for Andean people is equated to cultural genocide, given how closely the practice is tied to their very sense of belonging—far beyond the connections other cultures have to beer, tea, or coffee.

Coca Domesticated Thrice In Pre-columbian Era, Uniquely Sacred

Coca’s sacred and central status is reflected by its remarkable domestication history. DNA analysis shows all domesticated coca varieties descend from the wild Erythroxylum gracilipes, a shrub found on the eastern Andean slopes from Venezuela to Bolivia. In pre-Columbian times, Indigenous peoples domesticated coca independently on three separate occasions—in the Colombian Montaña, the Yungas of Bolivia and Peru, and the Northwest Amazon.

Despite these separate origins, coca achieved uniquely sacred status in each civilization. Its adoption highlights its inherent value to human flourishing and spirituality. In every region where coca was domesticated, it became the "plant of all plants," its spiritual status unwavering for at least 8,000 years and continuing to this day among its traditional users.

A powerful example of coca’s ritual importance is the Inca ceremony of Quyllur Rit’i, which involves a grueling Andean marathon. Young people and men run from 11,500 to ove ...

Coca's Legal Paradox Limits Research but Doesn't Stop Cocaine Production

The legal status of coca presents a complex paradox. Tim Ferriss notes that in Chile, coca’s legal status is uncertain, yet locals still provided him with coca leaf tea. In the United States, coca is classified as a Schedule 2 substance under the Controlled Substances Act—technically meaning it has recognized therapeutic applications but a high potential for abuse. Andrew Weil explains that coca landed in Schedule 2 only because cocaine, a derivative, is used medically in ophthalmology and dentistry. This placement, somewhat accidental, theoretically makes coca easier to study than Schedule 1 substances like cannabis and psychedelics, which are deemed to have no medical use.

Internationally, however, coca is classified even more harshly. Wade Davis highlights that the UN system lists coca leaf as Schedule 1—alongside [restricted term] and heroin—despite nearly 8,000 years of safe traditional use and the plant itself having no documented history of addiction or toxic overdose risk. The rationale for this classification is based on coca’s potential for cocaine extraction, yet, as Davis notes, this logic seems incoherent. For more than fifty years, international prohibition of coca has not impeded the cartels, who continue to produce cocaine by the ton, especially for the U.S. market. Legal or not, illicit cocaine production persists regardless of coca’s official status, and even if commercial export of coca were legalized, Davis argues, current enforcement controls over illicit cocaine would still apply.

Further complicating the paradox, Ferriss describes how one company in Maywood, New Jersey—Stepan Chemical—receives the only legal coca leaf export from Peru. Legally, they manufacture medical-grade cocaine and extract the rest of the leaf for use as a secret flavoring ingredient in Coca-Cola. The 1961 UN Convention on Narcotic Drugs even includes a specific exclusion for this commercial arrangement.

Regulations Hinder Access to Legal Coca Plant Material For Research

Despite coca’s Schedule 2 status theoretically providing a path for medical research, significant regulatory barriers remain. Andrew Weil details the challenges faced by Christopher McCurdy, a medicinal pharmacologist at the University of Florida, who pursued research into coca’s alkaloids and medicinal potential. Even with Schedule 2 status, obtaining actual coca leaves legally proved a "torturous route," involving daunting red tape around acquisition and importation. Unlike common Schedule 2 drugs synthesized in laboratories, scientific study of coca requires researchers to navigate a labyrinth of international, federal, and logistical hurdles to handle the plant itself.

Nevertheless, McCurdy recently managed to secure a supply of coca leaves for research. His work, beginning with animal studies, aims to disentangle the effects of coca’s different alkaloids, with a particular interest in its potential to regulate carbohydrate metabolism. McCurdy’s experience underscores how regulatory confusion and fear stemming from the association with cocaine severely hinder legitimate scientific investigation into coca, even as the plant remains technically less restricted than Schedule 1 substances ...

Introducing coca as a commercial product in the global marketplace requires a coordinated strategy spanning research, market development, policy reform, education, and advocacy. Experts including Tim Ferriss, Andrew Weil, and Wade Davis identify a series of actionable levers to move from prohibition and misunderstanding to innovation and integration.

Therapeutic Research: Key to FDA Approval and Commercialization

Robust therapeutic research is essential for FDA recognition and unlocking coca's legal and commercial potential. Andrew Weil emphasizes that even one compelling study showing coca's efficacy in treating gastrointestinal issues, aiding diabetes prevention, supporting weight reduction, or serving as a safer ADHD stimulant alternative could tip regulatory scales toward approval. He underscores the value of research demonstrating coca’s ability to help people transition from more dangerous stimulants, including treating cocaine use disorder. Ferriss and Weil discuss that the National Institute on Drug Abuse (NIDA) is open to funding such studies, reflecting a broader shift in federal attitudes toward exploring alternative therapies.

Start-up costs for these studies need not be prohibitive. Ferriss notes that early psychedelic research at Johns Hopkins in 2015 yielded meaningful results with modest grants (e.g., $50,000). These precedents suggest that well-designed, properly powered coca research with clear therapeutic outcomes could attract both government and social investment, potentially paving the way for further studies and eventual FDA approval.

Boosting North American Demand Accelerates Regulatory and Commercial Interest in Coca Products

Creating North American demand for coca-based products has the potential to challenge legal barriers and build commercial incentives. Consumer interest in coca’s benefits could drive market-driven policy reevaluation, much as increased demand for matcha led to industry growth over 15–20 years. Weil and Ferriss note matcha’s model—introduced against initial resistance, it became globally popular, which stressed producers’ capacity and demonstrated the power of persistent entrepreneurial commitment.

Additionally, research and anecdotal evidence indicate that those dependent on cocaine often prefer coca's much subtler effects, signifying coca’s promise as both a substitute therapy and a desirable functional product. Ferriss and Weil highlight the possibility of using coca in treating cocaine use disorder, drawing a parallel to how long-standing stigmas around other psychoactive plants have been overcome via both taste and utility.

Innovative Product Formulation Translates Traditional Coca Use into Modern Delivery Systems for New Consumers

Modern product innovation is vital to bridging traditional coca consumption and new marketplaces. Weil suggests adapting the traditional method of holding coca leaves in the mouth and slowly absorbing alkaloids through innovations such as lozenges, snus-style gum packets, mambé-style powder, or other slow oral absorption systems. These methods would enable consumers unfamiliar with coca customs to experience its benefits conveniently.

Weil and Davis also argue that, compared to coffee or pharmaceutical stimulants, coca offers a milder, more manageable stimulation profile, positioning it as a superior alternative alongside coffee, tea, and matcha in the global stimulant market.

Protecting Farmers from Cartel Violence and Creating State Revenue for Peace-Building Through Supporting Legal Coca Cultivation and Export

Legalizing and commercializing coca represents an opportunity to protect the livelihoods of Colombia’s 250,000 coca-growing families, who currently depend on illicit markets often controlled by violent cartels. Wade Davis discusses the failures of crop substitution programs, given coca’s portability and market value compared to alternatives like cacao or bananas.

State-sanctioned, legal coca exports could generate significant tax revenue to fund national peace-building efforts, especially after six decades of conflict fueled by the profits of prohibition. Davis points to the potential for cultivating coca on already deforested land, reducing additional rainforest destruction by shifting production away from forested frontiers that serve as cover for illicit crops.

Educational Storytelling: Reframing Coca’s Positive History and Cultural Significance

Changing attitudes toward coca requires not only evidence and policy change but also powerful educational storytelling. Davis, Ferriss, and Weil are raising funds for a documentary film exploring coca’s history, medicinal value, cultural importance, and the injustice of its prohibition. The film aims to reach broad audiences, offering narrative and emotional resonance that can correct misunderstandings and showcase coca’s legitimacy as more than just a drug precursor.

Such storytelling serves as "soft power," shifting public imagination and supporting scientific and regulatory progress. It provides context, h ...